Recombinant IL17A (Ixekizumab Biosimilar) antibody
This Mammalian Cells Monoclonal antibody specifically detects IL17A (Ixekizumab Biosimilar) in ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN7487783
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant IL17A (Ixekizumab Biosimilar) antibody (ABIN7487783)
Target
IL17A (Ixekizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This IL17A (Ixekizumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Ixekizumab Biosimilar - Anti-IL17A mAb
-
Characteristics
- Antibody Type: IgG4Kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG4 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 4°C for short term, -20°C for long term
-
-
- IL17A (Ixekizumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
Ixekizumab
Recombinant monoclonal antibody to IL17A. Ixekizumab is a humanized monoclonal antibody used in the treatment of autoimmune diseases.
Target
-
You are here:
